APA

Sakurai T., Sakurai A., Vaisman B. L., Amar M. J., Liu C., Gordon S. M., Drake S. K., Pryor M., Sampson M. L., Yang L., Freeman L. A. & Remaley A. T. (20160506). Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide. : The Journal of pharmacology and experimental therapeutics.

Chicago

Sakurai Toshihiro, Sakurai Akiko, Vaisman Boris L, Amar Marcelo J, Liu Chengyu, Gordon Scott M, Drake Steven K, Pryor Milton, Sampson Maureen L, Yang Ling, Freeman Lita A and Remaley Alan T. 20160506. Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide. : The Journal of pharmacology and experimental therapeutics.

Harvard

Sakurai T., Sakurai A., Vaisman B. L., Amar M. J., Liu C., Gordon S. M., Drake S. K., Pryor M., Sampson M. L., Yang L., Freeman L. A. and Remaley A. T. (20160506). Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide. : The Journal of pharmacology and experimental therapeutics.

MLA

Sakurai Toshihiro, Sakurai Akiko, Vaisman Boris L, Amar Marcelo J, Liu Chengyu, Gordon Scott M, Drake Steven K, Pryor Milton, Sampson Maureen L, Yang Ling, Freeman Lita A and Remaley Alan T. Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide. : The Journal of pharmacology and experimental therapeutics. 20160506.